GRAPHITE BIO INC (GRPH) Stock Analyst Ratings
NASDAQ:GRPH - Nasdaq - US38870X1046 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to GRPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 124.53% above the current price.
GRPH was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about GRPH.
In the previous month the buy percentage consensus was at a similar level.
GRPH was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-21 | RBC Capital | Maintains | Sector Perform |
| 2023-02-23 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-02-23 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2023-02-23 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-02-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-25 | BTIG | Downgrade | Buy -> Neutral |
| 2023-01-18 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-01-06 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2023-01-06 | RBC Capital | Maintains | Sector Perform |
| 2023-01-06 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-09-15 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-06-17 | BMO Capital | Initiate | Outperform |
| 2022-05-13 | SVB Leerink | Maintains | Outperform |
| 2022-04-14 | BTIG | Initiate | Buy |
| 2022-02-18 | RBC Capital | Initiate | Sector Perform |
| 2021-07-20 | SVB Leerink | Initiate | Outperform |
| 2021-07-20 | Cowen & Co. | Initiate | Outperform |
| 2021-07-20 | B of A Securities | Initiate | Buy |
| 2021-07-20 | Morgan Stanley | Initiate | Overweight |